ATLAS / Macro Radar / Reporting / SLXN

Silexion Therapeutics Corp (SLXN) reporting calendar

Silexion Therapeutics Corp files periodic reports with the SEC as SLXN on Nasdaq. Atlas tracks 8 filed reports for this issuer, each linked to its original EDGAR accession.

Next window
29 Jul 2026 – 1 Sep 2026
Latest report
10-Q
Period ended
31 Mar 2026
Filed
15 May 2026
Reports on record
8

How this window is derived. Derived from this issuer's own filing history: 8 periods at a median 92-day cadence, filed a median 45 days after period end. The SEC does not publish forward reporting dates and Atlas does not estimate one.

Open SLXN market profile Latest filing on SEC EDGAR ↗ Biological Products, (No Diagnostic Substances) reporting datesAll Nasdaq reporting dates

Filed periodic reports

FormPeriod endedFiledLagSEC accession
10-Q31 Mar 202615 May 202645 days0001178913-26-002744
10-K31 Dec 202517 Mar 202676 days0001178913-26-000953
10-Q30 Sep 202512 Nov 202543 days0001178913-25-003753
10-Q30 Jun 202512 Aug 202543 days0001178913-25-002804
10-Q31 Mar 202513 May 202543 days0001178913-25-001761
10-K31 Dec 202418 Mar 202577 days0001178913-25-000887
10-Q30 Sep 202414 Nov 202445 days0001178913-24-003686
10-Q30 Jun 202429 Aug 202460 days0001213900-24-073934

Source: SEC EDGAR company submissions for CIK 0002022416. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.